Mental Health Awareness Month: Seven Things to be Aware of

1
In this piece for Truthout, Noel Hunter lists seven facts it is important to be cognizant of during Mental Health Awareness Month, from the influence...

FDA: New Depression Drug “Not Approvable”

1
Gepirone, a new depression drug by Fabre-Kramer Pharmaceuticals, did not meet the FDAs efficacy standards. The new drug application for gepirone has now received...

Anticonvulsant Implicated in Birth Defects in up to 4,100 Children, French Study Finds

6
Between 2,150 and 4,100 children suffered from severe malformations connected to valproate prescription.

Whistleblower Files Lawsuit Against AstraZeneca

4
From the Chicago Tribune: Former drug sales representative Allison Zayas became a whistleblower against her old company, AstraZeneca, after learning that a combination of Seroquel...

Anticholinergic Medications Linked to Dementia Similar to Early Alzheimer’s

19
A new study, published in the Journal of Clinical Psychiatry, investigates the effects of anticholinergic medications, such as antidepressants and antipsychotics, on cognition in older adults diagnosed with schizophrenia.

Deprescribing: How to be on Less Medication for Healthier Aging

0
In this post for Better Health While Aging, Dr. Leslie Kernisan discusses the importance of making sure that older adults are taking the minimum amount...

Hospital Website Health Care Information May Not Be Reliable

4
An investigation found that many US hospital websites were more like advertising outlets than educational portals.
Berlin Manifesto launch

Berlin Manifesto for Humane Psychiatry Released

43
Changing the mental health and psychosocial support system in Germany requires public debate about the ways our society should help and support people in mental crisis and with chronic mental health problems. We believe the driving force behind all help and support should be humanitarianism and respect for inalienable human rights.

Poor and Foster Care Children More Likely to be Diagnosed and Treated with Psychiatric...

11
Study details Medicaid-insured birth cohort’s exposure to psychiatric medications and mental health services.

The ‘Choosing Wisely’ Campaign is Five Years Old

2
From MinnPost: The Choosing Wisely campaign, which was launched to promote informed consent among patients, is now five years old. The campaign has been very successful...

Systematic Review Finds Antidepressant Withdrawal Common and Potentially Long-lasting

27
Prominent researchers conduct a review of antidepressant withdrawal incidence, duration, and severity. Results lead to call for new clinical guidelines.

Why We Fell for Clean Eating

4
From The Guardian: Not only is the clean eating movement based on pseudoscientific beliefs not backed up by evidence, but it may also lead to...

“FDA Panel Votes to Remove Serious Warning from Pfizer’s Smoking Cessation Pill”

1
This week an FDA advisory panel decided to remove warnings of serious psychiatric side effects from the Chantix product label. “In making its recommendation,...

Researchers Identify Patterns in Antidepressant and Long-Term Benzodiazepine Use

1
The researchers found that, of those who were initially prescribed both antidepressants and benzodiazepines, approximately 12% went on to engage in long-term benzodiazepine use.

Appealing to our Elected Representatives

37
This is the final of four installments about the bizarre, ongoing conduct of psychiatrists at Upton House, an Eastern Health psychiatric facility in Melbourne, and the collusion with their conduct by all relevant agencies. This last installment will document the failure, so far, of the State and Federal Governments to intervene in even this most extreme and blatant example of abuse of power by psychiatry. If I, as a Professor of Clinical Psychology with 40 years clinical and research experience in this field, can be so easily dismissed/ignored by the relevant systems in Victoria, what chance do the average users of mental health services and their families have of being heard in this State?

After the Black-Box: Majority of Children Starting SSRIs Still Receiving Too High of Dose

19
In 2004, the FDA added a black-box warning to SSRI antidepressants on the increased risk of suicide among children taking these drugs. A new study suggests that this warning has increased the proportion of children who begin an antidepressant on a low dose, but the majority are still receiving higher than recommended doses.

Medical Interventions Are Overused Worldwide

3
Lack of “right care” causes physical, psychological and financial harm to patients

Forced Psychiatry is Torture

33
I am a survivor of forced psychiatry, and I bring this perspective with me as a human rights lawyer. People with disabilities have a right to be as we are and not to have our bodies and minds made over to suit other people. We alone have the right to decide whether a medical treatment will support who we are or detract from who we are, and that is why free and informed consent is the essential requirement.

What Animal Research Says About Sexual Side-effects of SSRIs

11
A group of researchers in Denmark examines what existing animal studies can tell us about the sexual side-effects of SSRI antidepressants.

Throwback Thursday: The Daily Show on the Pharmaceutical Drug Epidemic

1
On The Daily Show, Michael Che interviews MIA contributor Peter Gøtzsche and discovers that pharmaceutical companies and drug cartels have more in common than one might think.

Antidepressants During Pregnancy Increase Risk of Psychiatric Diagnosis in Children

6
New research, based on data from almost a million children in Denmark, suggests that children of mothers who use antidepressants during pregnancy are more likely to be diagnosed with autism and psychiatric disorders.

Online Communities for Drug Withdrawal: What Can We Learn?

3
From Psychiatric Times: Patients are increasingly turning to the internet as a source of information and support for antidepressant and benzodiazepine withdrawal due to the psychiatric...

Restoring Study 329: Letter to BMJ

6
When we set out to restore GSK’s misreported Study 329 of paroxetine for adolescent depression under the RIAT initiative, we had no idea of the magnitude of the task we were undertaking. After almost a year, we were relieved to finally complete a draft and submit it to the BMJ, who had earlier indicated an interest in publishing our restoration. But that was the beginning of another year of peer review that we believed went beyond enhancing our paper and became rather an interrogation of our honesty and integrity. Frankly, we were offended that our work was subject to such checks when papers submitted by pharmaceutical companies with fraud convictions are not.

Leah Harris and Tim Murphy Talk “Mental Illness and the Law”

2
Today on Radio Times, U.S. Representative Tim Murphy (R-PA), Mark Salzer, professor and chair of the Department of Rehabilitation Sciences at Temple University, and Leah...

SCOTUS Declines Risperdal Appeal, J&J to Pay $124 M

10
On Monday, the US Supreme Court declined to hear Johnson and Johnson’s final appeal, forcing the company to pay $124 million for the deceptive marketing of the antipsychotic Risperdal. In 2011, South Carolina ordered the company to pay $327 million for pursuing “profits-at-all-costs” in its efforts to persuade doctors to prescribe their drug, but the fine was lowered to $136 million last year. The company had hoped to argue that the remaining penalties constituted an “excessive fine” and was supported by PhRMA, the Washington Legal Foundation, the Cato Institute and the Chamber of Commerce.